TrendingVideosIndia
Opinions | CommentEditorialsThe MiddleLetters to the EditorReflections
UPSC | Exam ScheduleExam Mentor
State | Himachal PradeshPunjabJammu & KashmirHaryanaChhattisgarhMadhya PradeshRajasthanUttarakhandUttar Pradesh
City | ChandigarhAmritsarJalandharLudhianaDelhiPatialaBathindaShaharnama
World | ChinaUnited StatesPakistan
Diaspora
Features | The Tribune ScienceTime CapsuleSpectrumIn-DepthTravelFood
Business | My MoneyAutoZone
News Columns | Straight DriveCanada CallingLondon LetterKashmir AngleJammu JournalInside the CapitalHimachal CallingHill View
Don't Miss
Advertisement

Cadila arm to sell animal health business for Rs 2,921 crore

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Yearly Premium ₹999 ₹349/Year
Yearly Premium $49 $24.99/Year
Advertisement

New Delhi, May 12

Advertisement

Cadila Healthcare on Wednesday said its wholly-owned subsidiary Zydus Animal Health and Investment has entered into definitive pacts for sale of its animal healthcare established markets undertaking to Multiples Alternate Asset Management-led consortium for Rs 2,921 crore.

Advertisement

The consortium, including Canada Pension Plan Investment Board and RARE Enterprises, has agreed to purchase the undertaking through an special purpose vehicle controlled by them, in the name of Zenex Animal Health India, Cadila Healthcare said in a statement.

Animal Healthcare Established Markets Undertaking (Zydus AH) is focused on India and certain other countries, it added.Zydus AH employs around 700 people and has one manufacturing facility in Haridwar, it added. — PTI

Advertisement
Advertisement
Show comments
Advertisement